FDMT icon

4D Molecular Therapeutics
FDMT

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$30
245% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Eliana Merle
100% 1-yr FDMT win rate
28 Jan ‘26 1 month ago
Chardan Capital
Chardan Capital
Geulah Livshits
67% 1-yr FDMT win rate
18 Dec ‘25 2 months ago